Enjoy complimentary customisation on priority with our Enterprise License!
The anti-obesity drugs market size is forecast to increase by USD 18.33 billion at a CAGR of 14.44% between 2023 and 2028. The market is witnessing significant growth due to the global epidemic of energy imbalance, leading to an increase in calories consumed and expended disparities. This issue is particularly prevalent among children and adolescents, contributing to the rise of lifestyle-related illnesses such as cardiovascular disease. Factors such as stress, smoking, and drinking further exacerbate this trend. The market is driven by the research and development of drugs that target both obesity and type 2 diabetes mellitus. Additionally, the availability of anti-obesity devices through online pharmacies is increasing accessibility to these treatments. However, challenges remain, including the potential for side effects and the need for long-term adherence to treatment plans.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Drug Class
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.